In Vitro Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global In Vitro Diagnostics Market: Product Type (Reagents and Kits, Instruments, Software, Services), Technology Analysis (Immunoassay, Hematology, Microbiology, Urinalysis, Coagulation and Hemostasis, Others), Application Analysis (Diabetes, Cardiology, Oncology, Nephrology, HIV/AIDS, Drug Testing, Autoimmune Diseases, Others), By End-user (Hospitals, Laboratories, Academic Institutes, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

In Vitro Diagnostics Market size was valued at 88.13 Billion in 2021 and is estimated to reach 109.87 Billion by 2028, at a CAGR of 3.2% during the forecast period 2022 to 2028. In vitro diagnostics are used to detect infectious diseases, and also used to monitor the health status of a person and therapeutic procedures by examining the specimens like blood, tissue, urine, stools and other bodily fluids. Various technologies are incorporated in In Vitro Diagnostics Market as microarray techniques, mass spectrometry, polymerase chain reaction and sequencing technology are used for testing the sample preparation. Growing geriatric population, increased awareness of regular body profiling, particularly among health-conscious people, increasing need for rapid and error-free disease diagnosis, and technological advancements in in vitro diagnostic techniques are some of the key factors driving the global in vitro diagnostics market forward. In 2015 April, Abbott and Sekisui entered into an agreement for providing solutions of coagulation testing for laboratories across the world. In 2014 December, Roche expanded its CE-IVD for testing of human organ and tissue for next-gen blood screening assays. cobas MPX and Cobas WNV assays can be used to test tissue and human organ, therefore expanding the range of approved uses for the cobas 6800/8800 systems and assays. In vitro diagnostics are focusing on acquisitions, exclusive agreements and strategic collaborations in order to expand their business. In February 2015, Roche has acquired Signature Diagnostics to strengthen its cancer diagnostics. In February 2014, Thermo Fisher Scientific has acquired Life Technologies Corporation to strengthen it’s of next-generation sequencing space segment. Different organizations are being operated in order to monitor the industry. For example, BIVDA (British In Vitro Diagnostics Association) is an association of various companies in the UK which represents the manufacturers and distributors with high interest and involvement. Recently, Life Technology Corporation in Europe has launched CE-IVD Marked QuantStudio Dx Real-Time PCR instrument.

In vitro diagnostics market

MARKET SUMMARY
-
3.2.%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–3.2.%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

In Vitro Diagnostics Market

  •  In Vitro Diagnostics market is classified on the basis of product type, application, techniques, end user and geography
  • Increasing expenditure on healthcare sector in emerging markets, huge demand for novel diagnostic methods for diagnosis of the diseases are expected to create demand for in vitro diagnostics.
  • Rising adaptation of point care testing, rising incidences of lifestyle diseases are expected to boost the market. As per 2014 report of National Diabetes Statistics states that about 9.3% of U.S. population have diabetes and about 8.1 Mn people are undiagnosed, In accordance with WHO, about 5 Mn deaths were recorded because of the chronic diseases like TB, Malaria, and AIDS in 2011, around 8.7 Mn cases registered due to TB.
  • Cancer accounted for 7.9 Mn deaths and anticipated to reach 11 Mn by 2030. Increase in the number of laboratories with sophisticated infrastructure in developed countries is the few factors expected to boost the growth of In vitro diagnostics market. However, unfavourable reimbursement policies in developing countries and strict regulatory framework are few factors that are restraining the growth of the IVD market.
Market Key Players
  • Becton, Dickinson and Company
  •  Abbott Laboratories
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc
  • Sysmex Corporation
  • bioMérieux
  • Bio-Rad Laboratories, Inc
Growth

In Vitro Diagnostics Market

Incidences of chronic diseases are expected to rise in the coming years, according to the global health situation. Diseases including tuberculosis, diabetes, cancer, and cardiovascular disease are on the rise, and the large increase in patients suffering from these and other infectious and non-infectious diseases has been extremely beneficial to the in-vitro diagnostics market’s growth. The growing prevalence of various disorders around the world has boosted the market for in-vitro diagnostics. Prompt and accurate diagnosis has been critical in saving millions of lives, and this has directly led to an increase in global demand for IVD. In-vitro diagnostics, on the other hand, have improved substantially in recent years, adding new tests to existing sector offerings. Precision medicine, a developing diagnostic practise, has emerged as a result of technological advancements.


North-America Got Significant Share

In Vitro Diagnostics Market

North America is the largest market with the highest share of the IVD market, which is followed by the Europe owing easy accessibility for advanced technologies, the presence of the large pool of manufacturers in IVD market, increasing the prevalence of chronic genetic and lifestyle diseases. Asia-Pacific is expected to show fastest growth rate and also will emerge as the area with maximum growth potential owing to the improving infrastructure of the healthcare sector and growing economies in India and China.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • The report provides granular level information about the market size, regional market share, and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
In Vitro Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global In Vitro Diagnostics (IVD) Market Introduction
2.1. Global In Vitro Diagnostics (IVD) Market – Taxonomy
2.2. Global In Vitro Diagnostics (IVD) Market –Definitions
2.2.1. By Product Type
2.2.2. By Technology
2.2.3. By Application
2.2.4. By End User
3. Global In Vitro Diagnostics (IVD) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global In Vitro Diagnostics (IVD) Market Dynamics – Factors Impact Analysis
4. Global In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global In Vitro Diagnostics (IVD) Market Forecast, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028
5.1. Reagents and Kits
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Services
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global In Vitro Diagnostics (IVD) Market Forecast, By Technology, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Immunoassay
6.1.1. Enzyme-Linked Immunosorbent Assay
6.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Radioimmunoassay
6.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.1.3. Rapid Test
6.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3.3. Market Opportunity Analysis
6.1.4. Western Blotting
6.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.3. Market Opportunity Analysis
6.1.5. Enzyme-Linked Immunospot Assays
6.1.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.5.3. Market Opportunity Analysis
6.1.6. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.8. Market Opportunity Analysis
6.2. Hematology
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Microbiology
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Urinalysis
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Coagulation and Hemostasis
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global In Vitro Diagnostics (IVD) Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Diabetes
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Cardiology
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Oncology
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Nephrology
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. HIV/AIDS
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Drug Testing
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Autoimmune Diseases
7.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
7.8. Others
7.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.8.3. Market Opportunity Analysis
8. Global In Vitro Diagnostics (IVD) Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028
8.1. Hospitals
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Laboratories
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic Institutes
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global In Vitro Diagnostics (IVD) Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. The Middle East & Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product Type, By Technology, By Application, By End User, and Region, 2022 – 2028
10. North America In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
10.1. Product Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents and Kits
10.1.2. Instruments
10.1.3. Software
10.1.4. Services
10.2. Technology Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Immunoassay
10.2.1.1. Enzyme-Linked Immunosorbent Assay
10.2.1.2. Radioimmunoassay
10.2.1.3. Rapid Test
10.2.1.4. Western Blotting
10.2.1.5. Enzyme-Linked Immunospot Assays
10.2.2. Hematology
10.2.3. Microbiology
10.2.4. Urinalysis
10.2.5. Coagulation and Hemostasis
10.2.6. Others
10.3. Application Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Diabetes
10.3.2. Cardiology
10.3.3. Oncology
10.3.4. Nephrology
10.3.5. HIV/AIDS
10.3.6. Drug Testing
10.3.7. Autoimmune Diseases
10.3.8. Others
10.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Laboratories
10.4.3. Academic Institutes
10.4.4. Others
10.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2022 – 2028
10.7. North America In Vitro Diagnostics (IVD) Market Dynamics – Trends
11. Europe In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
11.1. Product Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents and Kits
11.1.2. Instruments
11.1.3. Software
11.1.4. Services
11.2. Technology Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Immunoassay
11.2.1.1. Enzyme-Linked Immunosorbent Assay
11.2.1.2. Radioimmunoassay
11.2.1.3. Rapid Test
11.2.1.4. Western Blotting
11.2.1.5. Enzyme-Linked Immunospot Assays
11.2.2. Hematology
11.2.3. Microbiology
11.2.4. Urinalysis
11.2.5. Coagulation and Hemostasis
11.2.6. Others
11.3. Application Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Diabetes
11.3.2. Cardiology
11.3.3. Oncology
11.3.4. Nephrology
11.3.5. HIV/AIDS
11.3.6. Drug Testing
11.3.7. Autoimmune Diseases
11.3.8. Others
11.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Laboratories
11.4.3. Academic Institutes
11.4.4. Others
11.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2022 – 2028
11.7. Europe In Vitro Diagnostics (IVD) Market Dynamics – Trends
12. Asia Pacific In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. Product Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents and Kits
12.1.2. Instruments
12.1.3. Software
12.1.4. Services
12.2. Technology Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Immunoassay
12.2.1.1. Enzyme-Linked Immunosorbent Assay
12.2.1.2. Radioimmunoassay
12.2.1.3. Rapid Test
12.2.1.4. Western Blotting
12.2.1.5. Enzyme-Linked Immunospot Assays
12.2.2. Hematology
12.2.3. Microbiology
12.2.4. Urinalysis
12.2.5. Coagulation and Hemostasis
12.2.6. Others
12.3. Application Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Diabetes
12.3.2. Cardiology
12.3.3. Oncology
12.3.4. Nephrology
12.3.5. HIV/AIDS
12.3.6. Drug Testing
12.3.7. Autoimmune Diseases
12.3.8. Others
12.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Laboratories
12.4.3. Academic Institutes
12.4.4. Others
12.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. ASEAN Counties
12.5.5. Philippines
12.5.6. Rest of Asia Pacific
12.6. Asia Pacific In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2022 – 2028
12.7. Asia Pacific In Vitro Diagnostics (IVD) Market Dynamics – Trends
13. Latin America In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
13.1. Product Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents and Kits
13.1.2. Instruments
13.1.3. Software
13.1.4. Services
13.2. Technology Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Immunoassay
13.2.1.1. Enzyme-Linked Immunosorbent Assay
13.2.1.2. Radioimmunoassay
13.2.1.3. Rapid Test
13.2.1.4. Western Blotting
13.2.1.5. Enzyme-Linked Immunospot Assays
13.2.2. Hematology
13.2.3. Microbiology
13.2.4. Urinalysis
13.2.5. Coagulation and Hemostasis
13.2.6. Others
13.3. Application Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Diabetes
13.3.2. Cardiology
13.3.3. Oncology
13.3.4. Nephrology
13.3.5. HIV/AIDS
13.3.6. Drug Testing
13.3.7. Autoimmune Diseases
13.3.8. Others
13.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Laboratories
13.4.3. Academic Institutes
13.4.4. Others
13.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Mexico
13.5.2. Brazil
13.5.3. Argentina
13.5.4. Chile
13.5.5. Rest of Latin America
13.6. Latin America In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2022 – 2028
13.7. Latin America In Vitro Diagnostics (IVD) Market Dynamics – Trends
14. Middle East and Africa In Vitro Diagnostics (IVD) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
14.1. Product Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents and Kits
14.1.2. Instruments
14.1.3. Software
14.1.4. Services
14.2. Technology Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Immunoassay
14.2.1.1. Enzyme-Linked Immunosorbent Assay
14.2.1.2. Radioimmunoassay
14.2.1.3. Rapid Test
14.2.1.4. Western Blotting
14.2.1.5. Enzyme-Linked Immunospot Assays
14.2.2. Hematology
14.2.3. Microbiology
14.2.4. Urinalysis
14.2.5. Coagulation and Hemostasis
14.2.6. Others
14.3. Application Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Diabetes
14.3.2. Cardiology
14.3.3. Oncology
14.3.4. Nephrology
14.3.5. HIV/AIDS
14.3.6. Drug Testing
14.3.7. Autoimmune Diseases
14.3.8. Others
14.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospitals
14.4.2. Laboratories
14.4.3. Academic Institutes
14.4.4. Others
14.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Saudi Arabia
14.5.4. Turkey
14.5.5. Rest of MEA
14.6. Middle East and Africa In Vitro Diagnostics (IVD) Market – Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2022 – 2028
14.7. Middle East and Africa In Vitro Diagnostics (IVD) Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Roche Diagnostics
15.2.2. Danaher Corporation
15.2.3. Abbott Laboratories, Inc.
15.2.4. Siemens AG
15.2.5. Sysmex Corporation
15.2.6. Thermo Fisher Scientific
15.2.7. Becton, Dickinson and Company
15.2.8. Biomérieux Sa
15.2.9. Bio-Rad Laboratories, Inc.
15.2.10. Johnson & Johnson
15.2.11. Agilent Technologies
15.2.12. Qiagen
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Roche Diagnostics
  • Danaher Corporation
  • Abbott Laboratories, Inc.
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • Biomérieux Sa
  • Bio-Rad Laboratories, Inc.
  • Johnson & Johnson
  • Agilent Technologies
  • Qiagen

Description

In Vitro Diagnostics Market size was valued at 88.13 Billion in 2021 and is estimated to reach 109.87 Billion by 2028, at a CAGR of 3.2% during the forecast period 2022 to 2028. In vitro diagnostics are used to detect infectious diseases, and also used to monitor the health status of a person and therapeutic procedures by examining the specimens like blood, tissue, urine, stools and other bodily fluids. Various technologies are incorporated in In Vitro Diagnostics Market as microarray techniques, mass spectrometry, polymerase chain reaction and sequencing technology are used for testing the sample preparation. Growing geriatric population, increased awareness of regular body profiling, particularly among health-conscious people, increasing need for rapid and error-free disease diagnosis, and technological advancements in in vitro diagnostic techniques are some of the key factors driving the global in vitro diagnostics market forward. In 2015 April, Abbott and Sekisui entered into an agreement for providing solutions of coagulation testing for laboratories across the world. In 2014 December, Roche expanded its CE-IVD for testing of human organ and tissue for next-gen blood screening assays. cobas MPX and Cobas WNV assays can be used to test tissue and human organ, therefore expanding the range of approved uses for the cobas 6800/8800 systems and assays. In vitro diagnostics are focusing on acquisitions, exclusive agreements and strategic collaborations in order to expand their business. In February 2015, Roche has acquired Signature Diagnostics to strengthen its cancer diagnostics. In February 2014, Thermo Fisher Scientific has acquired Life Technologies Corporation to strengthen it’s of next-generation sequencing space segment. Different organizations are being operated in order to monitor the industry. For example, BIVDA (British In Vitro Diagnostics Association) is an association of various companies in the UK which represents the manufacturers and distributors with high interest and involvement. Recently, Life Technology Corporation in Europe has launched CE-IVD Marked QuantStudio Dx Real-Time PCR instrument.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX